[1] Kamangar F,Dores GM,Anderson WF. Patterns of cancer incidence,mortality and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world[J]. J Clin Oncol,2006,4:2137-2150. [2] Japanese committee for registration of esophageal carcinoma. A proposal for a new TNM classification of esophageal carcinoma[J]. Jpn J Clin Oocol,1985,15:625-636. [3] Japanese committee for registration of esophageal carcinoma. Parameters linked to ten-years survival in Japan in resected cases of esophageal carcinoma[J]. Chest,1989,6:1005-1011. [4] 程贵余,张大为.食管癌的国际TNM分期(1987)与我国临床病理分期标准的进一步比较[J].中华肿瘤杂志,1993,15:358-361. [5] Korst RJ,Rusch VW,Venkatraman E,et al. Proposed revision of the staging classification for esophageal cancer[J]. J Thorac Cardiovasc Surg,1998,115:660-670. [6] Killinger WA,Rice TW,Adelstein DJ,et al. Stage Ⅱ esophageal carcinoma:the significance of T and N[J].J Thorac Cardiovasc Surg,1996,111:935-940. [7] Ellis FH,Watkins E,Krasna MJ,et al. Staging of carcinoma of the esophagus and cardia: a comparison of different staging criteria[J]. J Surg Oncol,1993,52:231-235. [8] Steup WH,De Leyn P,Deneffe G,et al. Tumors of the esophagogastric junction: long term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification[J]. J Thorac Cardiovasc Surg,1996,111:85-95. [9] Skinner DB,Little AG,Ferquson MK,et al. Selection of operation for esophageal cancer based on staging[J]. Ann Surg,1986,204:391-401. [10] Roder JD,Busch R,Stein HJ,et al. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus[J].Br J Surg,1994,81:410-413. [11] Hagen JA,Peters JH,DeMeester TR. Superiority of extended en bloc esophagogastrectomy for carcinoma of the lower esophagus and cardia[J]. J Thorac Cardiovasc Surg,1993,106:850-890. [12] Kimura H,Konishi K,Arakawa H,et al. Number of lymph node metastases influences survival in patients with thoracic esophageal carcinoma: therapeutic value of radiation treatment for recurrence[J]. Dis Esophagus,1999,12:205-208. [13] Clark GW,Smyrk TC,Burdiles P,et al. Is Barrett′s metaplasia the source of adenocarcinomas of the cardia[J]. Arch Surg,1994,129:609-614. [14] Eloubeidi MA,Desmond R,Arquedas MR,et al. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status[J].Cancer,2002,95:1434-1443. [15] Tachibana M,Yoshimura H,Kinugasa S,et al. Clinicolpathological factors correlated with number of metastatic lymph nodes in esophageal cancer[J]. Digest Liver Dis,2001,33:534-538. [16] Tachibana M,Kinugasa S,Dhar DK,et al. Prognostic factors after extended esophagectomy for squamous cell carcinoma of the thoracic esophagus[J]. J Surg Oncol,1999,72:88-93. [17] Tachibana M,Tabara H,Kotoh T,et al. Prognostic significancer of perioperative blood transfusions in respectable thoracic esophageal cancer[J]. Am J Gastroenterol,1999,94:757-765. [18] Tachibana M,Kinugasa S,Dhar DK,et al. Prognostic factors in T1 and T2 squamous cell carcinoma of the thoracic esophagus[J]. Arch Surg,1999,134:50-54. [19] Rice TW,Blackstone EH,Rybicki LA,et al. Refining esophageal cancer staging[J]. J Thorac Cardiovasc Surg,2003,125:1103-1113. [20] Wijnhoven BP,Tran KT,Esterman A,et al. An evaluation of prognostic factors and tumor staging fo resected carcinoma of the esophagus[J].Ann Surg,2007,245:717-725. [21] Hagen JA,DeMeester SR,Peters JH,et al. Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies[J]. Ann Surg,2001,234:520-531. [22] Thompson SK,Ruszkiewicz AR,Jamieson GG,et al. Improving the accuracy of TNM staging in esophageal cancer: a pathological review of resected specimens[J]. Ann Surg Oncol,2008,15:3447-3458. [23] Tabira Y,Yssunaga M,Nakano KY,et al. All pathological T4 esophageal carcinomas should be categorized as stage Ⅳ[J]. Hepato-Gastroenterology,2002,49:694-698. [24] Lagarde SM,ten Kate FJ,Reitsma JB,et al. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction[J].J Clin Oncol,2006,26:4347-4355. [25] Hofstetter W,Correa AM,Bekele N,et al. Proposed modification of nodal status in AJCC esophageal cancer staging system[J]. Ann Thorac Surg,2007,84:365-375. [26] Dickson GH,Singh KK,Escofet X,et al. Validation of a modified GTNM classification in peri-junctional oesophagogastric carcinoma and its use as a prognostic indicator[J]. Eur J Surg Oncol,2001,27:641-644. [27] Wind J,Lagarde SM,Ten Kate FJ,et al. A systematic review on the significancer of extracapsular lymph node involvement in gastrointestinal malignancies[J]. Eur J Surg Oncol,2007,33:401-408. [28] Dexter SP,Sue-Ling H,McMahon MJ,et al. Circumferential resection margin involvement: an independent predictor of survival following surgery for oesophageal cancer[J].Gut,2001,48:667-670. [29] Zhang HL,Chen LQ,Liu RL,et al. The number of lymph node metastases influences survival and international union against cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma[J]. Dis Esophagus,2010,23:53-58. [30] Xiao ZF,Yang ZY,Miao YJ,et al. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases[J]. Int J Radiat Oncol Biol Phys,2005,62:82-90. [31] Wilson M,Rosato EL,Chojnacki KA,et al. Prognostic significance of lymph node metastases and ration in esophageal cancer[J]. J Surg Res,2008,146:11-15. [32] Ellis FH,Heatley GJ,Balogh K,et al. Proposal for improved staging criteria for carcinoma of the esophagus and cardia[J]. Eur J Cardiothorac Surg,1997,12:361-365. [33] Kunisaki C,Akiyama H,Nomura M,et al. Developing an appropriate staging system for esophageal carcinoma[J]. J Am Coll Surg,2005,201:884-890. [34] Bollschweiler E,Baldus SE,Schrder W,et al. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes: are these independent prognostic factors[J]. J Surg Oncol,2006,94:355-363. [35] De Manzoni G,Pedrazzani C,Verlato G,et al. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction[J]. Br J Surg,2004,91:296-303. [36] Hu Y,Hu C,Zhang H,et al. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma[J]. Ann Surg Oncol,2010,17:784-790. [37] Peyre CG,Hagen JA,DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection[J]. Ann Surg,2008,248:549-556. [38] Rizk N,Venkatraman E,Park B,et al. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer Staging System[J]. J Thorac Cardiovasc Surg,2006,32:1374-1381. [39] Dutkowski P,Hommel G,Bttqer T,et al. How many lymph nodes are needed for an accurate pN classification in esophageal cancer.Evidence for a new threshold value[J]. Hepato-Gastroenterol,2002,49:176-180. [40] Bogoevski D,Onken F,Koenig A,et al. Is it time for a new TNM classification in esophageal carcinoma[J]. Ann Surg,2008,247:633-641. [41] Sujendran V,Wheeler J,Baron R,et al. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with respectable esophageal cancer[J]. Br J Surg,2008,95:191-194. [42] Hulscher JB,Buskens CJ,Berqman JJ,et al. Positive peritruncal nodes for esophageal carcinoma: not always a dismal prognosis[J]. Dig Surg,2001,18:98-101. [43] Christie NA,Rice TW,DeCamp MM,et al. M1a/M1b esophageal carcinoma: clinical relevance[J]. J Thorac Cardiovasc Surg,1999,118:900-907. [44] Sieweert JR,Stein HJ. Classification of adenocarcinoma of the esophagogastric junction[J]. Br J Surg,1998,85:1457-1459. [45] De Manzoni G,Pedrazani C,Pasini F,et al. Results of surgical treatment of adenocarcinoma of the gastric cardia[J]. Ann Thorac Surg,2002,73:1035-1040. [46] Mariette C,Castel B,Toursel H,et al. Surgical management of and long-term survival after adenocarcinoma of the cardia[J]. Br J Surg,2002,89:1156-1163. [47] Hulscher JB,van Sandick JW,Tijssen JG,et al. The recurrence pattern of esophageal carcinoma after transhiatal resection[J]. J Am Coll Surg,2000,191:143-148. [48] Wang LS,Wu CW,Hsieh MJ,et al. Lymph node metastasis in patients with adenocarcinoma of gastric cardia[J]. Cancer,1993,71:1948-1953. [49] 方文涛.第7版国际抗癌联盟食管鳞癌TNM分期解读[J].上海交通大学学报(医学版),2011,31:265-270. [50] HX,Wei JC,Xu Y,et al. Modification of nodal categories in the seventh American joint committee of cancer staging system for esophageal squamous cell carcinoma in chinese patients[J]. Ann Thorac Surg,2011,92:216-225. [51] Xu Y,Jiang Y,Yu X,et al. Analysis of new N-category on prognosis of oesophageal cancer with positive lymph nodes in a Chinese population[J]. Radiol Oncol,2013,47:63-70. [52] Reeh M,Nentwich MF,von Loga K,et al. An attempt at validation of the seventh edition of the classification by the international union against cancer for esophageal carcinoma[J]. Ann Thorac Surg,2012,93:890-896.
2014, Vol. 23 
